New Brunswick reports second blood clot death linked to Oxford-AstraZeneca vaccine

·1 min read

FREDERICTON — New Brunswick is reporting a second death related to a rare blood-clotting event from the Oxford-AstraZeneca vaccine.

Chief medical officer of health Dr. Jennifer Russell says a person in their 50s received a first dose on April 11 and developed blood clot symptoms 17 days later and died recently.

Health officials say the case had been reported previously and the person involved had been hospitalized.

Officials are reporting 15 new cases of COVID-19 today.

New Brunswick has 127 active reported cases and seven people in hospital with the disease, including three in intensive care.

Officials are asking the public to follow public health advice and avoid unnecessary travel during the holiday long weekend.

This report by The Canadian Press was first published May 21, 2021.

The Canadian Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting